Colistimethate Sodium (Colistin methanesulfonate sodium) contains not less than 11500 IU/mg of mixture of di to penta bis-sulfomethylated primary amine derivatives, mainly polymyxins E1 and E2., calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

申請商
宇直泰貿易股份有限公司 
適應症
抗生素
含量
發證日期
2024-04-15